Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,965 public trials 2,022 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Allogenic CD19-targeting CAR-γδT Cell Therapy in R/R NHL

NCT05554939

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: School of phamaceutical, Tsinghua University Beijing, Beijing Municipality, China

Biotherapeutic Department, Chinese PLA General Hospital Beijing, China

View Trial Details

Recruiting

ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma

NCT07106710

Conditions: Bites and Stings, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib

NCT06812715

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Peter MacCallum Cancer Centre Melbourne, Victoria, Australia

Alfred Hospital Melbourne, Victoria, Australia

Monash Medical Centre Melbourne, Victoria, Australia

View Trial Details

Recruiting

Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous Lineage

NCT04440267

Conditions: Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: HBDH Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Clinical Study of the Safety and Efficacy of ASCT Combined With CD7-CART in the Treatment of CD7+ TCL

NCT07106723

Conditions: CD7 Positive, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

NCT06365060

Conditions: Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +15 more
Locations: University of Alabama Hospital Birmingham, Alabama, United States

Cedars-Sinai Medical Center Los Angeles, California, United States

University of California, San Francisco San Francisco, California, United States

Cleveland Clinic Florida, Weston Hospital Weston, Florida, United States

View all 13 locations

View Trial Details

Recruiting

CD180 CART for Relapsed or Refractory CD180 Positive Hematologic Malignancies

NCT07106749

Conditions: Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia/Lymphoma, Burkitt Lymphoma, +20 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

NCT05841550

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Oslo Myeloma Center Oslo, Norway

View Trial Details

Recruiting

BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma

NCT06793449

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Recruiting

BCMA CAR-T for Dynamic High-risk Multiple Myeloma

NCT06880393

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences Tianjin, China

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions